Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $35.9500 (-4.89%) ($34.5000 - $37.8000) on Thu. Feb. 1, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.74% (three month average) | RSI | 79 | Latest Price | $35.9500(-4.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.8% a day on average for past five trading days. | Weekly Trend | ATRA advances 17.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -2.87% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-11%) UNG(-4%) TIP(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.87% (StdDev 5.74%) | Hourly BBV | 0 () | Intraday Trend | -4.8% | | | |
|
5 Day Moving Average | $37.7(-4.64%) | 10 Day Moving Average | $35.6(0.98%) | 20 Day Moving Average | $29.62(21.37%) | To recent high | -10.7% | To recent low | 172.3% | Market Cap | $2.671b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |